Back

Oxygen uptake efficiency slope is a valid marker of exercise capacity in pediatric and adult Fontan patients

4 April 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Exercise testing Exercise Testing EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Haluk Tekerlek

Karamanoglu Mehmetbey University, Karaman (Turkiye)

5 More presentations in this session

Presentation thumbnail
Relationship between the fick principle and cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy
Doctor R. Willixhofer (Milan, IT)
Abstract Slides
Presentation thumbnail
Prognostic values of cardiopulmonary exercise testing parameters for different peak respiratory exchange ratios in patients with cardiovascular disease
Ms M. Ikeda (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
Evaluating macronutrient oxidation rates during cardiopulmonary exercise test: validation of ramp vs step graded protocol
Doctor L. Nesti (Pisa, IT)
Abstract Slides
Presentation thumbnail
The adding value of non-invasive assessment of stroke volume during cardiopulmonary exercise testing in hypertrophic cardiomyopathy: beyond O2-pulse
Doctor M. Mapelli (Milan, IT)
Abstract Slides
Presentation thumbnail
Increased cardiometabolic index is associated with impaired exercise capacity and heart failure with preserved ejection fraction in old hypertensives
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides

Access the full session

Session thumbnail
Exercise testing

The Event

Event poster

ESC Preventive Cardiology 2025

4 April 2025 10:00 CET
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Presentation
Premature ventricular beats in the athlete: beyond PVC burden
thumbnail
Congress Session
Challenges in sports eligibility: what to do with…

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources